Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4406761000168110 | Dimaval (2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg / 5 mL) injection, 5 x 5 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4406771000168116 | Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | Is a | 2,3-bis(sulfanyl)propane-1-sulfonate sodium 250 mg/5 mL injection, 5 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | has TP | Dimaval | true | Inferred relationship | Some | ||
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | has TPUU | Dimaval 250 mg/5 mL injection, 5 mL ampoule | true | Inferred relationship | Some | 716550494 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | Is a | True | Dimaval 250 mg/5 mL injection, 5 x 5 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR